Affective neuropsychiatric symptoms (aNPS: depression, anxiety, apathy, irritability) have been linked to increased dementia risk. However, less is known whether this association is independent of Alzheimer’s disease (AD) pathophysiology.
Objective:
To investigate the contribution of early aNPS to dementia risk in cognitively normal (CN) older adults and mild cognitive impairment (MCI) patients, with and without AD biomarker abnormality.
Methods:
Participants included 763 community-dwelling, stroke-free older adults identified as CN and 617 with MCI at baseline, drawn from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. Baseline assessments included a neuropsychological battery, the Neuropsychiatric Inventory (NPI), and apolipoprotein E ɛ4 (ApoE4) genotyping. A participant subset completed cerebrospinal fluid (CSF) AD biomarker assessment. Time to progression to dementia was measured based on months at follow-up when an individual was diagnosed with dementia, over the follow-up period of 48 months.
Results:
Latent class analysis identified 3 subgroups of older adults in CN and MCI, indicated by the baseline profiles of neuropsychiatric symptoms (NPS). Subgroups with higher aNPS were at increased risk of progression to dementia in both CN (HR = 3.65, 95% CI [1.80, 7.40]) and MCI (HR = 1.52, 95% CI [1.16, 2.00]; HR = 1.86 [1.05, 3.30]) groups, adjusting for age, sex, global cognition, and ApoE4, compared with their counterparts with minimal NPS. There was no difference between higher aNPS and minimal NPS subgroups in their CSF AD biomarker profiles.
Conclusion:
Findings suggest that aNPS may represent a neurobiological vulnerability that uniquely contribute to the dementia risk, independent of AD biomarker profiles.
MastersMC, MorrisJC, RoeCM (2015) “Noncognitive” symptoms of early Alzheimer disease: A longitudinal analysis. Neurology84, 617–622.
2.
ModregoPJ, FerrándezJ (2004) Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study. Arch Neurol61, 1290–1293.
3.
Van der MusseleS, FransenE, StruyfsH, LuyckxJ, MariënP, SaerensJ, SomersN, GoemanJ, De DeynPP, EngelborghsS (2014) Depression in mild cognitive impairment is associated with progression to Alzheimer’s disease: A longitudinal study. J Alzheimers Dis42, 1239–1250.
SacuiuS, InselPS, MuellerS, TosunD, MattssonN, JackCR, DeCarliC, PetersenR, AisenPS, WeinerMW, MackinRS (2016) Chronic depressive symptomatology in mild cognitive impairment is associated with frontal atrophy rate which hastens conversion to Alzheimer dementia. Am J Geriatr Psychiatry24, 126–135.
6.
RobertPH, BerrC, VolteauM, BertogliatiC, BenoitM, SarazinM, LegrainS, DuboisB (2006) Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer’s disease. Clin Neurol Neurosurg108, 733–736.
7.
RobertPH, BerrC, VolteauM, Bertogliati-FileauC, BenoitM, GuerinO, SarazinM, LegrainS, DuboisB (2008) Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry16, 770–776.
8.
PalmerK, Di IulioF, VarsiAE, GianniW, SancesarioG, CaltagironeC, SpallettaG (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: The role of depression and apathy. J Alzheimers Dis20, 175–183.
9.
Vicini ChiloviB, ContiM, ZanettiM, MazzùI, RozziniL, PadovaniA (2009) Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord27, 390–398.
10.
RichardE, SchmandB, EikelenboomP, YangSC, LigthartSA, Moll van CharanteEP, van GoolWA (2012) Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer’s disease in non-depressed subjects. Dement Geriatr Cogn Disord33, 204–209.
11.
PalmerK, BergerAK, MonasteroR, WinbladB, BackmanL, FratiglioniL (2007) Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology68, 1596–1602.
12.
MahL, BinnsMA, SteffensDC (2015) Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Am J Geriatr Psychiatry23, 466–476.
13.
RamakersIHGB, VisserPJ, AaltenP, KesterA, JollesJ, VerheyFRJ (2010) Affective symptoms as predictors of Alzheimer’s disease in subjects with mild cognitive impairment: A 10-year follow-up study. Psychol Med40, 1193–1201.
14.
CooperC, SommerladA, LyketsosCG, LivingstonG (2015) Modifiable predictors of dementia in mild cognitive impairment: A systematic review and meta-analysis. Am J Psychiatry172, 323–334.
15.
MouraoRJ, MansurG, Malloy-DinizLF, Castro CostaE, DinizBS (2016) Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: Systematic review and meta-analysis: MCI, depression and risk of dementia. Int J Geriatr Psychiatry31, 905–911.
16.
LiJ-Q, TanL, WangH-F, TanM-S, TanL, XuW, ZhaoQ-F, WangJ, JiangT, YuJ-T (2016) Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: A systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry87, 476–484.
17.
GedaYE, RobertsRO, MielkeMM, KnopmanDS, ChristiansonTJH, PankratzVS, BoeveBF, SochorO, TangalosEG, PetersenRC, RoccaWA (2014) Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study. Am J Psychiatry171, 572–581.
18.
GulpersB, RamakersI, HamelR, KöhlerS, Oude VoshaarR, VerheyF (2016) Anxiety as a predictor for cognitive decline and dementia: A systematic review and meta-analysis. Am J Geriatr Psychiatry24, 823–842.
19.
LeoutsakosJ-MS, ForresterSN, LyketsosCG, SmithGS (2015) Latent classes of neuropsychiatric symptoms in NACC controls and conversion to mild cognitive impairment or dementia. J Alzheimers Dis48, 483–493.
20.
GedaYE, SchneiderLS, GitlinLN, MillerDS, SmithGS, BellJ, EvansJ, LeeM, PorsteinssonA, LanctôtKL, RosenbergPB, SultzerDL, FrancisPT, BrodatyH, PadalaPP, OnyikeCU, OrtizLA, Ancoli-IsraelS, BliwiseDL, MartinJL, VitielloMV, YaffeK, ZeePC, HerrmannN, SweetRA, BallardC, KhinNA, AlfaroC, MurrayPS, SchultzS, LyketsosCG, Neuropsychiatric Syndromes Professional Interest Area of ISTAART (2013) Neuropsychiatric symptoms in Alzheimer’s disease: Past progress and anticipation of the future. Alzheimers Dement9, 602–608.
21.
SperlingRA, AisenPS, BeckettLA, BennettDA, CraftS, FaganAM, IwatsuboT, JackCR, KayeJ, MontineTJ, ParkDC, ReimanEM, RoweCC, SiemersE, SternY, YaffeK, CarrilloMC, ThiesB, Morrison-BogoradM, WagsterMV, PhelpsCH (2011) Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 280–292.
RamakersIHGB, VerheyFRJ, ScheltensP, HampelH, SoininenH, AaltenP, RikkertMO, VerbeekMM, SpiruL, BlennowK, TrojanowskiJQ, ShawLM, VisserPJ, the Alzheimer’s Disease Neuroimaging Initiative and DESCRIPA Investigators (2013) Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychol Med43, 911–920.
26.
DonovanNJ, HsuDC, DagleyAS, SchultzAP, AmariglioRE, MorminoEC, OkerekeOI, RentzDM, JohnsonKA, SperlingRA, MarshallGA (2015) Depressive symptoms and biomarkers of Alzheimer’s disease in cognitively normal older adults. J Alzheimers Dis46, 63–73.
27.
ShowrakiA, MurariG, IsmailZ, BarfettJJ, FornazzariL, MunozDG, SchweizerTA, FischerCE (2019) Cerebrospinal fluid correlates of neuropsychiatric symptoms in patients with Alzheimer’s disease/mild cognitive impairment: A systematic review. J Alzheimers Dis71, 477–501.
28.
BanningLCP, RamakersIHGB, DeckersK, VerheyFRJ, AaltenP (2019) Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer’s disease: A systematic literature review. Neurosci Biobehav Rev107, 346–359.
29.
MuellerSG, WeinerMW, ThalLJ, PetersenRC, JackC, JagustW, TrojanowskiJQ, TogaAW, BeckettL (2005) The Alzheimer’s Disease Neuroimaging Initiative. Neuroimaging Clin N Am15, 869–877.
30.
EdmondsEC, Delano-WoodL, ClarkLR, JakAJ, NationDA, McDonaldCR, LibonDJ, AuR, GalaskoD, SalmonDP, BondiMW, Alzheimer’s Disease Neuroimaging Initiative (2015) Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement11, 415–424.
31.
CummingsJL, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2308.
32.
KauferDI, CummingsJL, KetchelP, SmithV, MacMillanA, ShelleyT, LopezOL, DeKoskyST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci12, 233–239.
33.
ClarkCM,
SchneiderJA,
BedellBJ,
BeachTG,
BilkerWB,
MintunMA,
PontecorvoMJ,
HeftiF,
CarpenterAP,
FlitterML,
KrautkramerMJ,
KungHF,
ColemanRE,
DoraiswamyPM,
FleisherAS,
SabbaghMN,
SadowskyCH,
ReimanEM,
ZehntnerSP,
SkovronskyDM, for the AV45-A07 Study Group (2011) Use of Florbetapir-PET for imaging β-amyloid pathology. JAMA305, 275–283.
34.
ClarkLR, Delano-WoodL, LibonDJ, McDonaldCR, NationDA, BangenKJ, JakAJ, AuR, SalmonDP, BondiMW (2013) Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?. J Int Neuropsychol Soc19, 635–645.
35.
CollinsLM, LanzaST (2010) Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences. John Wiley & Sons, New Jersey.
36.
Van DamD, VermeirenY, DekkerAD, NaudéPJ, DeynPP (2016) Neuropsychiatric disturbances in Alzheimer’s disease: What have we learned from neuropathological studies?. Curr Alzheimer Res13, 1145–1164.
37.
RensmaSP, van SlotenTT, LaunerLJ, StehouwerCDA (2018) Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis. Neurosci Biobehav Rev90, 164–173.
38.
WoutsL, KesselM, BeekmanATF, MarijnissenRM, Oude VoshaarRC (2020) Empirical support for the vascular apathy hypothesis: A structured review. Int J Geriatr Psychiatry35, 3–11.
39.
CanevelliM, AdaliN, VoisinT, SotoME, BrunoG, CesariM, VellasB (2013) Behavioral and psychological subsyndromes in Alzheimer’s disease using the Neuropsychiatric Inventory: Behavioral subsyndromes in Alzheimer’s disease. Int J Geriatr Psychiatry28, 795–803.
40.
for the NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART), IsmailZ, Agüera-OrtizL, BrodatyH, CieslakA, CummingsJ, FischerCE, GauthierS, GedaYE, HerrmannN, KanjiJ, LanctôtKL, MillerDS, MortbyME, OnyikeCU, RosenbergPB, SmithEE, SmithGS, SultzerDL, LyketsosC (2017) The Mild Behavioral Impairment Checklist (MBI-C): A rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis56, 929–938.
41.
WurptsIC, GeiserC (2014) Is adding more indicators to a latent class analysis beneficial or detrimental? Results of a Monte-Carlo study. Front Psychol5, 920.
